Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-01 Sale |
2022-07-01 4:45 pm |
Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director |
2,735,853 | $55 | $150,471,915 | 0 (Indirect Direct) |
View |
| 2022-01-31 Purchase |
2022-01-31 6:47 pm |
Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner |
800,000 | $27 | $21,600,000 | 2,735,853 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Conversion |
2025-02-19 11:55 am |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
1,400,000 | $0 | 11,373,271 (Indirect) |
View |
| 2024-10-09 Conversion |
2024-10-10 5:15 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
5,500,000 | $0 | 9,974,037 (Indirect) |
View |
| 2024-05-09 Option Award |
2024-05-10 4:05 pm |
N/A 2034-05-08 |
GERON CORP | GERN | Aggarwal Gaurav Director |
180,000 | $0 | 180,000 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 7:02 pm |
N/A N/A |
GERON CORP | GERN | Aggarwal Gaurav Director |
1,970 | $0 | 1,970 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:10 pm |
N/A 2033-11-25 |
GERON CORP | GERN | Aggarwal Gaurav Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-09-05 Option Award |
2023-09-07 4:30 pm |
2024-09-05 2033-09-05 |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
180,000 | $0 | 180,000 (Direct) |
View |
| 2023-07-11 Conversion |
2023-07-13 8:42 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
59,961,729 | $0 | 59,961,729 (Indirect) |
View |
| 2023-07-11 Conversion |
2023-07-13 8:42 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
8,077 | $1000 | 59,961,729 (Indirect) |
View |
| 2023-03-08 Option Award |
2023-03-09 9:39 pm |
N/A N/A |
Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director |
8,077 | $1000 | 8,077 (Indirect) |
View |
| 2022-01-26 Exercise |
2022-01-28 7:53 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner |
1,935,661 | $13.2 | 1,935,853 (Indirect) |
View |
| 2021-06-08 Option Award |
2021-06-09 10:29 am |
N/A 2031-06-08 |
Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner |
6,000 | $0 | 6,000 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-10 6:58 pm |
N/A 2030-06-09 |
Sierra Oncology Inc. | SRRA | Aggarwal Gaurav Director 10% Owner |
6,874 | $0 | 6,874 (Direct) |
View |